CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FiercePharma
High ImpactOriginal article

{"a":[{"_":"Curium strikes up to $8B deal for radiopharma rival Lantheus","$":{"href":"/medtech/curium-strikes-8b-deal-radiopharma-rival-lantheus","hreflang":"en"}}]}

Positive
AI Analysis

Summary

Curium has agreed to acquire Lantheus in an all-cash deal valued at up to $8 billion, combining two leading radiopharma companies. The transaction follows months of speculation about a potential takeover.

Importance:8/10
Sentiment:
0.70
M&Aradiopharmaacquisition
Related Companies

Read the original article

Published by FiercePharma on August 3, 2026 1:56 PM

Read Original